Preparation of microcapsules from complex coacervation of Gantrez-gelatin. III. Bioavailability of nitrofurantoin microcapsules. 1988

S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Egypt.

The bioavailability of marketed nitrofurantoin capsules was compared to capsules filled with Gantrez-gelatin nitrofurantoin microcapsules of a core:coat ratio of 1:2. The collective results obtained from the analysis of urine samples of five volunteers indicated that nitrofurantoin microcapsules provided a prolonged release compared with that of the control formulation. Analysis of variance showed statistically significant differences between the control formulation and the capsule filled with the microcapsule. Non-significant intersubject variation was noticed.

UI MeSH Term Description Entries
D009582 Nitrofurantoin A urinary anti-infective agent effective against most gram-positive and gram-negative organisms. Although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression. Furadantin,Furadantine,Furadoine,Furadonine,Furantoin,Macrodantin,Nitrofurantoin Sodium Salt,Nitrofurantoin, Monohydrate
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
July 2023, Carbohydrate polymers,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
January 1995, Journal of microencapsulation,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
January 2014, Carbohydrate polymers,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
September 2018, Pharmaceutical development and technology,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
May 1997, Journal of pharmaceutical sciences,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
May 1980, Journal of pharmaceutical sciences,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
January 1995, Journal of biomaterials science. Polymer edition,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
April 1999, Drug development and industrial pharmacy,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
May 2009, Indian journal of pharmaceutical sciences,
S A Mortada, and M A el Egaky, and A M Motawi, and K A el Khodery
February 2004, Journal of microencapsulation,
Copied contents to your clipboard!